No Data
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation
Express News | Foghorn Therapeutics Inc.: Strong Balance Sheet With Cash, Cash Equivalents, and Marketable Securities of $243.8 Mln Provides Cash Runway Into 2027
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
Foghorn Therapeutics (FHTX) Upgraded to Strong Buy: Here's What You Should Know
Foghorn Therapeutics Board Member Resignation Announced
Foghorn Therapeutics Price Target Lowered to $4 From $9 at Morgan Stanley
Daily Investors : Hey I started a Bio Tech group, I know your on the same exact thing. If you want in you can. It is only for Bio and Major Pharm. But just what iv put in their over the weekend and today. Def worth it, if you want in send me a FR and I'll add you in
Daily Investors : * Editas Medicine laid off 65% of its workforce after failing to find a partner for its reni-cel program.
* Medtronic's latest PillCam completed its first patient procedure.
* AbbVie acquired oral peptide biotech Nimble for $200 million.
* Novartis paid PTC $1 billi...
Trytosaveabit OP Daily Investors : Thank you! I’ll have to think it over. I’m so busy already that I’m not sure if I’ll be able to contribute much! But again thank you